Harbin Medisan Pharmaceutical issued an abnormal announcement, there is no need to correct or supplement the information disclosed earlier by the company; the company has not found any undisclosed significant information that may or has had a significant impact on the trading price of the company's stocks recently reported by the public media; the company's recent operational situation is normal, and there have been no significant changes in the internal and external business environment; after verification, there are no significant matters that should be disclosed but have not been disclosed by the company, its controlling shareholder, or actual controller, nor are there any significant matters in the planning stage; after verification, the company's controlling shareholder and actual controller did not engage in trading the company's stocks during periods of abnormal stock fluctuations.